All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
CAR-CQ0731 | Anti-CYP7B1 (M17-P3F2) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | M17-P3F2 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ0732 | Anti-CYP7B1 (CBXC-3051) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBXC-3051 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ0733 | Anti-CYP7B1 (CBXC-3065) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBXC-3065 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ4155 | Anti-CYP7B1 (M17-P3F2) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | M17-P3F2 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ4156 | Anti-CYP7B1 (CBXC-3051) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBXC-3051 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ4157 | Anti-CYP7B1 (CBXC-3065) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBXC-3065 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY3061 | Anti-CYP7B1 (CBFYC-2578) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBFYC-2578 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY6314 | Anti-CYP7B1 (CBFYC-2578) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBFYC-2578 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WJ0735 | Anti-CYP7B1 (CBWJC-2111) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBWJC-2111 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WJ0736 | Anti-CYP7B1 (CBWJC-3579) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBWJC-3579 | Rabbit | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WJ3027 | Anti-CYP7B1 (CBWJC-2111) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBWJC-2111 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WJ3028 | Anti-CYP7B1 (CBWJC-3579) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBWJC-3579 | Rabbit | scFv-CD28-CD3ζ | Lentiviral vector | T cell |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION